Prescribing decisions affected by student interaction with marketers

Article

Medical trainees who spend more time with pharmaceutical marketing representatives are less likely to make evidence-based choices when prescribing, according to a study recently published in JAMA Internal Medicine.

Medical trainees who spend more time with pharmaceutical marketing representatives are less likely to make evidence-based choices when prescribing, according to a study recently published in JAMA Internal Medicine.

Researchers surveyed a randomly selected, nationally representative sample of first- and fourth-year medical students, as well as third-year residents.

Study: 90 percent of health-related Wikipedia articles contain errors

“All trainees were asked how often they used different educational resources to learn about prescription drugs. Among fourth-year students and residents, we posed a series of multiple choice knowledge questions asking about the appropriate initial therapy for clinical scenarios involving patients with diabetes, hyperlipidemia, hypertension, and difficulty sleeping,” the study’s authors say.

Participants were also asked about frequency in the past six months of interactions with the pharmaceutical industry, their expected frequency of interactions in their careers, and their attitudes about such interactions. Researchers used the survey answers to build an industry relations index assessing each trainee’s level of acceptance of pharmaceutical promotion.

The study found that 48 percent to 90 percent of fourth-year students and residents accurately identified evidence-based prescribing choices. According to researchers, a 10-point higher industry relations index was associated with 15 percent lower odds of selecting an evidence-based prescribing choice. The study also found there was a significant association between the industry relations index and greater odds of choosing to prescribe brand-name drugs.

The study also found that the 1601 students and 735 residents who participated reported common use of unfiltered sources of drug information such as Google (74.2 percent to 88.9 percent) and Wikipedia (45.2 percent to 84.5 percent).

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Shelby Brogdon, OD, details opportunities for practices to answer the patient's concerns from the chair before they hit the internet for their contact lens needs.
Christi Closson, OD, FAAO, shares her excitement for the new Acuvue Oasys MAX 1-Day multifocal for astigmatism
Karen R. Hoffman, OD, shares how customizable scleral lenses can transform vision for patients with complex corneas, achieving 20/20 outcomes and enhanced comfort.
Janna Pham, OD, shares key takeaways from a corneal tomography session she presented alongside Travis Pfeifer, OD, and Matthew McGee, OD.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
When Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, began fitting scleral lenses 20 years ago, there was limited knowledge about conjunctival characteristics, scleral shape, and lens behavior.
Ioussifova details what sets Johnson & Johnson's new lens apart from the rest, which was launched at the American Optometric Association's Optometry's Meeting 2025.
Alongside Rachel Steele, OD, Rafieetary outlines what to look for in blurred disc margins and the importance of acting fast and sending patients to the ED when needed.
Langis Michaud, OD, MSc, FAAO, FSLS, FBCLA, FEAOO, emphasized that every staff member should play a role in myopia management during his presentation at Optometry's Meeting 2025.
Dr Ashley Tucker Wallace discusses the intersection of pediatric dry eye and myopia control
© 2025 MJH Life Sciences

All rights reserved.